Status:
COMPLETED
A Relative Bioavailability Study of 100 mg Flavoxate Hydrochloride Tablets Under Fasting Conditions
Lead Sponsor:
Padagis LLC
Conditions:
Healthy
Eligibility:
All Genders
18-75 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to compare the relative bioavailability of Flavoxate Hydrochloride tablets 100mg manufactured by Paddock Laboratories, Inc., with that of Urispas® tablets 100mg by SmithKl...
Eligibility Criteria
Inclusion
- Good health as determined by lack of clinically significant abnormalities in health assessment performed at screening
Exclusion
- Positive test results for HIV or Hepatitis B or C
- History of allergy or sensitivity to Flavoxate hydrochloride or related drugs
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00992238
Last Update
July 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PRACS Institute, Ltd
Fargo, North Dakota, United States, 58104